Association between depression and the subsequent risk of Parkinson's disease: a meta-analysis
Abstract
Background Observational studies, including recent large cohort studies, have reported an association between depression and the risk of Parkinson's disease (PD); however, conclusions were inconsistent. Clarifying this relation might improve the understanding of risk factors for and the disease mechanisms in PD. Therefore, we performed a meta-analysis to examine whether depression is associated with an increased risk of PD. Methods A literature search in the PubMed, EMBASE, Scopus, PsycINFO and Web of Science databases was undertaken through March 2018, looking for observational studies evaluating the association between depression and the risk of PD. Pooled relative risk (RR) estimates and 95% confidence intervals (CIs) were calculated using a random-effects model. Subgroup analyses and sensitivity analyses were also performed. Results A random-effects meta-analysis of 5 cohort studies and 6 case-control studies demonstrated a significant positive association between depression and a subsequent risk of PD (RR, 2.20; 95% CI, 1.87-2.58), and it was consistent across subgroups. Furthermore, sensitivity analysis confirmed the stability of the results; visual examination of funnel plots and Begg's and Egger's tests showed no evidence of publication bias. Conclusions Our meta-analysis demonstrated that persons with depression exhibited an increased risk of a subsequent PD diagnosis. The pathophysiological and psychological mechanisms underlying this association are still unclear a…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In primary care, people with schizophrenia are less likely to have had a physical examination such as weight or blood pressure.
“In primary care, people with schizophrenia are less likely to have had a physical examination (e.g.weight, blood pressure), 109”
From The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness (2019) · cites this paper as [109]
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · see citing works
Stang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396 · see citing works
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010) · International Journal of Surgery · doi:10.1016/j.ijsu.2010.02.007 · Cited by 12,156 · see citing works
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works
The prevalence of Parkinson's disease: a systematic review and meta-analysis
Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. L. (2014) · Movement Disorders · doi:10.1002/mds.25945 · Cited by 2,188 · see citing works
Ownby, R. L., Crocco, E., Acevedo, A., John, V., & Loewenstein, D. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.5.530 · Cited by 1,493 · see citing works
The role of dopamine in the pathophysiology of depression
Dunlop, B. W., & Nemeroff, C. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.327 · Cited by 1,244 · see citing works
Rémy, P., Doder, M., Lees, A. J., Turjanski, N., & Brooks, D. J. (2005) · Brain · doi:10.1093/brain/awh445 · Cited by 1,046 · see citing works
Prediagnostic presentations of Parkinson’s disease in primary care: A case-control study
Schrag, A., Horsfall, L., Walters, K., Noyce, A., & Petersen, I. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70287-x · Cited by 674 · see citing works
Higher incidence of depression preceding the onset of Parkinson's disease: A register study
Leentjens, A. F. G., van den Akker, M., Metsemakers, J. F. M., Lousberg, R. L., & Verhey, F. R. J. (2003) · Movement Disorders · doi:10.1002/mds.10387 · Cited by 339 · see citing works
Dong, J.-Y., Zhang, Y., Tong, J., & Qin, L. (2011) · Stroke · doi:10.1161/strokeaha.111.630871 · Cited by 328 · see citing works
A systematic review of depression and mental illness preceding Parkinson's disease
Ishihara, L., & Brayne, C. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00579.x · Cited by 312 · see citing works
Risk factors for Parkinson's disease
Hubble, J. P., Cao, T., Hassanein, R. E. S., Neuberger, J. S., & Roller, W. C. (1993) · Neurology · doi:10.1212/wnl.43.9.1693 · Cited by 279 · see citing works
Increased risk of Parkinson’s disease after depression
Schuurman, A. G., van den Akker, M., Ensinck, K., Metsemakers, J. F. M., Knottnerus, J. A., Leentjens, A. F. G., & Buntinx, F. (2002) · Neurology · doi:10.1212/wnl.58.10.1501 · Cited by 270 · see citing works
Depression and subsequent risk of Parkinson disease
Gustafsson, H., Nordström, A., & Nordström, P. (2015) · Neurology · doi:10.1212/wnl.0000000000001684 · Cited by 211 · see citing works
Immune-to-Brain Communication Pathways in Inflammation-Associated Sickness and Depression
D’Mello, C., & Swain, M. G. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_37 · Cited by 210 · see citing works
Parkinson's Disease and Neurodegeneration: GABA-Collapse Hypothesis
Błaszczyk, J. W. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00269 · Cited by 187 · see citing works
Nilsson, F. M., Kessing, L. V., & Bolwig, T. G. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00372.x · Cited by 180 · see citing works
Occurrence of depression and anxiety prior to Parkinson’s disease
Jacob, E. L., Gatto, N. M., Thompson, A. W., Bordelon, Y. M., & Ritz, B. R. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.06.014 · Cited by 162 · see citing works
Early speech and language development in children with velocardiofacial syndrome
Scherer, N. J., DʼAntonio, L. L., & Kalbfleisch, J. H. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19991215)88:6 · Cited by 145 · see citing works
Anxious personality predicts an increased risk of Parkinson's disease
Bower, J. H., Grossardt, B. R., Maraganore, D. M., Ahlskog, J. E., Colligan, R. C., Geda, Y. E., Therneau, T. M., & Rocca, W. A. (2010) · Movement Disorders · doi:10.1002/mds.23230 · Cited by 141 · see citing works
Risk of Parkinson disease after depression
Shen, C., Tsai, S., Perng, C., Kuo, B. I., & Yang, A. C. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a956ad · Cited by 134 · see citing works
Risk factors of Parkinson's disease in Indian patients
Behari, M., Srivastava, A. K., Das, R. R., & Pandey, R. M. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00578-0 · Cited by 133 · see citing works
The Epidemiology of Parkinson’s Disease in an Australian Population
McCann, S. J., Couteur, D. G. L., Green, A. C., Brayne, C., Johnson, A. G., Chan, D., McManus, M. E., & Pond, S. M. (1998) · Neuroepidemiology · doi:10.1159/000026185 · Cited by 124 · see citing works
Relationship between depression and cognitive dysfunctions in Parkinson’s disease without dementia
Santangelo, G., Vitale, C., Trojano, L., Longo, K., Cozzolino, A., Grossi, D., & Barone, P. (2009) · Journal of Neurology · doi:10.1007/s00415-009-0146-5 · Cited by 101 · see citing works
Depression and the subsequent risk of Parkinson's disease in the NIH‐AARP Diet and Health Study
Fang, F., Xu, Q., Park, Y., Huang, X., Hollenbeck, A. R., Blair, A. E., Schatzkin, A. G., Kamel, F., & Chen, H. (2010) · Movement Disorders · doi:10.1002/mds.23092 · Cited by 96 · see citing works
Symptoms of anxiety and depression and risk of acute myocardial infarction: the HUNT 2 study
Gustad, L. T., Laugsand, L. E., Janszky, I., Dalen, H., & Bjerkeset, O. A. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht387 · Cited by 91 · see citing works
Use of antidepressants and the risk of Parkinson's disease: a prospective study
Alonso, Á., Rodríguez, L. A. G., Logroscino, G., & Hernán, M. Á. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.152983 · Cited by 91 · see citing works
Current trends in etiology, prognosis and therapeutic aspects of Parkinson's disease: a review.
Jagadeesan, A. J., Murugesan, R., Devi, S. V., Meera, M. V. S., Madhumala, G., Padmaja, M. V., Ramesh, A., Banerjee, A., Sushmitha, S., Khokhlov, A. N., et al. (2017) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v88i3.6063 · Cited by 89 · see citing works
Nilsson, F. M., Kessing, L. V., & Bolwig, T. G. (2001) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2001.00372.x · Cited by 72 · see citing works
Corticotropin-Releasing Hormone, Glutamate, and γ-Aminobutyric Acid in Depression
Gao, S., & Bao, A. (2010) · The Neuroscientist · doi:10.1177/1073858410361780 · Cited by 71 · see citing works
Cognitive and Motor Function in Patients with Parkinson's Disease with and without Depression
Cubo, E., Bernard, B., Leurgans, S. E., & Raman, R. (2000) · Clinical Neuropharmacology · doi:10.1097/00002826-200011000-00006 · Cited by 70 · see citing works
Environmental and Familial Risk Factors of Parkinsons Disease: Case-Control Study
Sanyal, J., Chakraborty, D. P., Sarkar, B., Banerjee, T. K., Mukherjee, S. C., Ray, B. C., & Rao, V. R. (2010) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100010829 · Cited by 67 · see citing works
Influence of depression in mild Parkinson's disease on longitudinal motor and cognitive function
Ng, A. Y. T., Chander, R. J., Tan, L. C. S., & Kandiah, N. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.06.014 · Cited by 52 · see citing works
Prospective association between emotional health and clinical evidence of Parkinson’s disease
Ishihara-Paul, L., Wainwright, N. W. J., Khaw, K., Luben, R., Welch, A. A., Day, N., Brayne, C., & Surtees, P. G. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02299.x · Cited by 51 · see citing works
Anxiety and Depression Are Better Correlates of Parkinson’s Disease Quality of Life Than Apathy
Jones, J. D., Butterfield, L. C., Song, W., Lafo, J., Mangal, P. C., Okun, M. S., & Bowers, D. (2014) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.13120380 · Cited by 48 · see citing works
Anxiety and Depression in Parkinson’s Disease
Djamshidian, A., & Friedman, J. H. (2014) · Current Treatment Options in Neurology · doi:10.1007/s11940-014-0285-6 · Cited by 47 · see citing works
Huang, P., Lou, Y., Xuan, M., Gu, Q., Guan, X., Xu, X., Song, Z., Luo, W. F., & Zhang, M. (2016) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2016.03.002 · Cited by 43 · see citing works
Personality, depression, and premorbid lifestyle in twin pairs discordant for Parkinson's disease
Heberlein, I., Ludin, H. P., Scholz, J., & Vieregge, P. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.2.262 · Cited by 40 · see citing works
Psychiatric diseases predated the occurrence of Parkinson disease: a retrospective cohort study
Lin, H., Lin, H., & Chen, Y. (2014) · Annals of Epidemiology · doi:10.1016/j.annepidem.2013.12.010 · Cited by 40 · see citing works
Prevalence of depression in Parkinson’s disease in a Lebanese tertiary clinic
Ghaddar, A., Fawaz, M. W., Khazen, G., Abdallah, J., & Milane, A. (2015) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2015.1087466 · Cited by 12 · see citing works
The association of Parkinson’s disease pathogenesis with inflammation
Saiki, S. (2014) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.54.1125 · Cited by 10 · see citing works
[Depression in Parkinson's disease and its relation to the cognitive and motor manifestations].
Saladié, D. G. I., González, M. D., Ley, C. O., Peña‐Casanova, J., & Barraquer Bordas, L. (1992) · PubMed · Cited by 5 · see citing works
Divisón, J. A., Cervantes, C. E., & Díaz, M. S. (2015) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2015.01.007 · Cited by 2 · see citing works
Correlation of Parkinson's disease severity and duration with123I-FP-CIT SPECT striatal uptake
Benamer, H. T. S., Patterson, J., Wyper, D. J., Hadley, D. M., Macphee, G. J. A., & Grosset, D. G. (2000) · Movement Disorders · doi:10.1002/1531-8257(200007)15:4
Flagged first, then by citations
Cited by
Sorted by citations
Firth, J., Siddiqi, N., Koyanagi, A., Siskind, D., Rosenbaum, S., Galletly, C., Allan, S., Caneo, C., Carney, R., Carvalho, A. F., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30132-4 · Cited by 1,531 · see citing works
Neuroinflammation and depression: A review
Troubat, R., Barone, P., Leman, S., Desmidt, T., Cressant, A., Atanasova, B., Brizard, B., El Hage, W., Surget, A., Belzung, C., et al. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14720 · Cited by 1,107 · see citing works
Berk, M., Köhler‐Forsberg, O., Turner, M., Penninx, B. W. J. H., Wrobel, A., Firth, J., Loughman, A., Reavley, N. J., McGrath, J. J., Momen, N. C., et al. (2023) · World Psychiatry · doi:10.1002/wps.21110 · Cited by 336 · see citing works
Szymkowicz, S. M., Gerlach, A., Homiack, D., & Taylor, W. D. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02464-9 · Cited by 212 · see citing works
The association between triglyceride glucose index and depression: data from NHANES 2005–2018
Shi, Y., Zheng, R., Cai, J., & Qian, S. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03275-2 · Cited by 150 · see citing works
Ahmad, M. H., Rizvi, M. M. A., Ali, M., & Mondal, A. C. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101840 · Cited by 134 · see citing works
Higher HEI-2015 Score Is Associated with Reduced Risk of Depression: Result from NHANES 2005–2016
Wang, K., Zhao, Y., Nie, J., Xu, H., Yu, C., & Wang, S. (2021) · Nutrients · doi:10.3390/nu13020348 · Cited by 133 · see citing works
Self-citationAssociation Between Depression and Physical Conditions Requiring Hospitalization
Frank, P., Batty, G. D., Pentti, J., Jokela, M. M., Poole, L., Ervasti, J. M., Vahtera, J., Lewis, G., Steptoe, A., & Mika Kivimaki, B. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.0777 · Cited by 121 · see citing works
Massey, A., Boag, M. K., Magnier, A., Bispo, D. P. C. F., Khoo, T. K., & Pountney, D. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112928 · Cited by 101 · see citing works
Lipocalin 2 as a link between ageing, risk factor conditions and age-related brain diseases
Dekens, D. W., Eisel, U. L. M., Gouweleeuw, L., Schoemaker, R. G., Deyn, P. P. D., & Naudé, P. J. W. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101414 · Cited by 93 · see citing works
Han, X., Hou, C., Yang, H., Chen, W., Ying, Z., Sun, Y., Qu, Y., Qu, Y., Yang, L., Valdimarsdóttir, U. A., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01170-6 · Cited by 90 · see citing works
Optimal Treatment of Depression and Anxiety in Parkinson's Disease
Pontone, G. M., & Mills, K. A. (2021) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2021.02.037 · Cited by 67 · see citing works
Kazmi, H., Walker, Z., Booij, J., Khan, F., Shah, S., Sudre, C. H., Buckman, J. E. J., & Schrag, A. E. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-324266 · Cited by 66 · see citing works
Prevalence of Prodromal Symptoms of Parkinson’s Disease in the Late Middle-Aged Population
Roos, D. S., Klein, M., Deeg, D. J. H., Doty, R. L., & Berendse, H. W. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-213007 · Cited by 61 · see citing works
Jo, Y., Kim, S., Ye, B. S., Lee, E., & Yu, Y. M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.837890 · Cited by 60 · see citing works
(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression
Wang, X., Yang, J., & Hashimoto, K. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104762 · Cited by 62 · see citing works
Klompmaker, J. O., Laden, F., Browning, M. H. E. M., Dominici, F., Jimenez, M. P., Ogletree, S. S., Rigolon, A., Zanobetti, A., Hart, J. E., & James, P. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.47664 · Cited by 53 · see citing works
Non-Genetic Risk Factors for Parkinson’s Disease: An Overview of 46 Systematic Reviews
Chen, Y., Sun, X., Lin, Y., Zhang, Z., Gao, Y., & Wu, I. X. Y. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-202521 · Cited by 52 · see citing works
Agüera-Ortíz, L., García-Ramos, R., Pérez, F. J. G., López‐Álvarez, J., Rodríguez, J. M. M., Rodríguez, F. J. O., Pueyo, J. O., Valero, C. P., & Porta-Etessam, J. (2021) · Parkinson s Disease · doi:10.1155/2021/6621991 · Cited by 41 · see citing works
Murayama, R., Cai, Y., Nakamura, H., & Hashimoto, K. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106209 · Cited by 41 · see citing works
Waddington, J. L. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0373-y · Cited by 36 · see citing works
Dry Eye and Phacoemulsification Cataract Surgery: A Systematic Review and Meta-Analysis
Lü, Q., Lü, Y., & Zhu, X. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.649030 · Cited by 35 · see citing works
Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trial
Bradley, E., Sakai, K., Fernandes‐Osterhold, G., Szigeti, B., Ludwig, C., Ostrem, J. L., Tanner, C. M., Bock, M., Llerena, K., Finley, P. R., et al. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02097-0 · Cited by 31 · see citing works
Bareeqa, S. B., Samar, S. S., Kamal, S., Masood, Y., Allahyar, Ahmed, S. I., & Hayat, G. R. (2022) · Neurodegenerative Disease Management · doi:10.2217/nmt-2022-0001 · Cited by 28 · see citing works
Shen, X., Gu, X. F., Liu, Y.-Y., Yang, L., Zheng, M., & Jiang, L. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1042522 · Cited by 29 · see citing works
Christodoulou, C. C., Onisiforou, A., Zanos, P., & Papanicolaou, E. Z. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1273855 · Cited by 27 · see citing works
Tufail, M. (2019) · Neurodegenerative Diseases · doi:10.1159/000506742 · Cited by 27 · see citing works
Ren, C., Li, L.-X., Dong, A.-Q., Zhang, Y., Hu, H., Mao, C., Wang, F., & Liu, C. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00095 · Cited by 27 · see citing works
Novel targets for parkinsonism-depression comorbidity
Tizabi, Y., Getachew, B., Csoka, A. B., Manaye, K. F., & Copeland, R. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.06.004 · Cited by 25 · see citing works
Mood disturbances in Parkinson's disease: From prodromal origins to application of animal models
Hayley, S. P., Vahid-Ansari, F., Sun, H., & Albert, P. R. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106115 · Cited by 23 · see citing works
The Increasing Economic Burden with Additional Steps of Pharmacotherapy in Major Depressive Disorder
Arnaud, A. M., Suthoff, E. D., Tavares, R. M., Zhang, X., & Ravindranath, A. J. (2021) · PharmacoEconomics · doi:10.1007/s40273-021-01021-w · Cited by 20 · see citing works
Risk of Parkinson Disease in Individuals With Autism Spectrum Disorder
Yin, W., Reichenberg, A., Beeri, M. S., Levine, S. Z., Ludvigsson, J. F., Figee, M., & Sandin, S. (2025) · JAMA Neurology · doi:10.1001/jamaneurol.2025.1284 · Cited by 20 · see citing works
Tuon, T., Meirelles, S. S., de Moura, A. B., Rosa, T., Borba, L. A., Botelho, M. E. M., Abelaira, H. M., de Mathia, G. B., Danielski, L. G., Fileti, M. E., et al. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113226 · Cited by 19 · see citing works
Bidirectional Mendelian randomization study of psychiatric disorders and Parkinson’s disease
Wu, Q., Liu, S., Huang, X., Liu, J., Wang, Y., Xiang, Y., Tang, X., Xu, Q., Yan, X., Tang, B., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1120615 · Cited by 19 · see citing works
Klompmaker, J. O., Mork, D., Zanobetti, A., Braun, D., Hankey, S., Hart, J. E., Hystad, P., Jimenez, M. P., Laden, F., Larkin, A., et al. (2024) · Environment International · doi:10.1016/j.envint.2024.108739 · Cited by 18 · see citing works
CSF α-synuclein correlates with CSF neurogranin in late-life depression
Bruno, D., Plaska, C. R., Clark, D. P. A., Zetterberg, H., Blennow, K., Verbeek, M. M., & Pomara, N. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1744596 · Cited by 17 · see citing works
Papa, D., Ingenito, A., von Gal, A., Pandis, M. F. D., & Piccardi, L. (2025) · Biomedicines · doi:10.3390/biomedicines13051023 · Cited by 17 · see citing works
Chen, J., Huang, Y. X., & Li, X. (2024) · Brain and Behavior · doi:10.1002/brb3.3467 · Cited by 17 · see citing works
Huang, C.-H., Lin, M., & Hsieh, C. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.591640 · Cited by 15 · see citing works
The Role of Cannabinoid Type 2 Receptors in Parkinson’s Disease
Basile, M. S., & Mazzon, E. (2022) · Biomedicines · doi:10.3390/biomedicines10112986 · Cited by 15 · see citing works
Integrated Care Models for Older Adults with Depression and Physical Comorbidity: A Scoping Review
Tops, L., Beerten, S. G., Vandenbulcke, M., Vermandere, M., & Deschodt, M. (2024) · International Journal of Integrated Care · doi:10.5334/ijic.7576 · Cited by 14 · see citing works
Age or age of onset: which is the best criterion to classify late-life depression?
Olgiati, P., Fanelli, G., & Serretti, A. (2023) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000472 · Cited by 13 · see citing works
Association between dietary flavonoid intake and depressive symptoms: A cross-sectional research
Deng, M., Liu, F., Wang, K., Zhang, M.-J., Feng, Q., & Liu, J. (2023) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2023.12.005 · Cited by 13 · see citing works
Kratter, I. H., Jorge, A., Feyder, M. T., Whiteman, A. C., Chang, Y., Henry, L. C., Karp, J. F., & Richardson, R. M. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01978-y · Cited by 13 · see citing works
Brazdis, R.-M., von Zimmermann, C., Lenz, B., Kornhuber, J., & Mühle, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063219 · Cited by 12 · see citing works
Stocchi, F., Antonini, A., Barone, P., Bellelli, G., Fagiolini, A. M., Ferini‐Strambi, L., Sorbi, S., & Padovani, A. (2023) · Neurological Sciences · doi:10.1007/s10072-023-06740-w · Cited by 12 · see citing works
Bono, A. D., Twaite, J. T., Krch, D., McCabe, D. L., Scorpio, K. A., Stafford, R. J., & Borod, J. C. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-822290-4.00015-3 · Cited by 12 · see citing works
Cognition, motor symptoms, and glycolipid metabolism in Parkinson’s disease with depressive symptoms
Yao, C., Niu, L., Fu, Y., Zhu, X., Yang, J., Zhao, P., Sun, X., Ma, Y., Li, S., & Li, J. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02437-6 · Cited by 11 · see citing works
Heng, H., Liu, J., Hu, M., Li, D., Su, W., & Li, J. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1013745 · Cited by 10 · see citing works
Different risks of early-onset and late-onset Parkinson disease in individuals with mental illness
Yoon, S. Y., Lee, S. C., Suh, J. H., Yang, S. N., Han, K., & Kim, Y. W. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-023-00621-x · Cited by 9 · see citing works
Hu, W., Zhao, C.-H., Huang, Y., Liu, B.-P., & Jia, C.-X. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00810-2 · Cited by 9 · see citing works
Early-Life Stress Induces Prodromal Features of Parkinsonism in Ageing Rats
Ren, C., Wang, F., He, K.-J., Zhang, Y., Li, L.-X., Zhang, J., Chen, J., Mao, C., & Liu, C. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab253 · Cited by 9 · see citing works
Association between osteoarthritis and the incidence of Parkinson’s disease in the United Kingdom
Jacob, L., Smith, L., Koyanagi, A., Schnitzler, A., Shin, J. I., & Kostev, K. (2021) · Clinical Parkinsonism & Related Disorders · doi:10.1016/j.prdoa.2021.100120 · Cited by 9 · see citing works
Choi, K., Lee, H. J., Han, K., Koh, S., Im, J. P., & Kim, J. S. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1014290 · Cited by 8 · see citing works
Chan, Y. E., Chen, M., Bai, Y., Li, C., Chen, T., & Su, T. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.01.056 · Cited by 8 · see citing works
Reduced striatal dopamine transmission as a transdiagnostic substrate of psychomotor retardation
Leong, I. L., Ng, T. H., Sen, K., Burchill, E., Costello, H., Badenoch, J., Coebergh, J. W. W., McCutcheon, R. A., Nair, A., Browning, M. D., et al. (2025) · Brain · doi:10.1093/brain/awaf335 · Cited by 7 · see citing works
Mano, M., Nomura, A., & Sasanabe, R. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030914 · Cited by 7 · see citing works
Depressive Symptoms and the Subsequent Risk of Parkinson's Disease: A Nationwide Cohort Study
Yoon, S. Y., Heo, S., Kim, Y. W., Lee, S. C., Shin, J., & Lee, J. W. (2023) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2023.10.006 · Cited by 7 · see citing works
Rajkumar, R. P. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1455606 · Cited by 6 · see citing works
On the heterogeneity of depression in Parkinson’s disease
Nodel, M. R., & Yakhno, N. N. (2020) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2020-5-46-52 · Cited by 6 · see citing works
Prevention of Parkinson’s Disease: From Risk Factors to Early Interventions
Ng, M. G., Chan, B. J. L., Koh, R. Y., Ng, K. Y., & Chye, S. M. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230616092054 · Cited by 6 · see citing works
Khazai, O. F., Pishyareh, E., Rassafiani, M., Bakhshi, E., & Poursadeqiyan, M. (2019) · فصلنامه علمی پژوهشی توانبخشی · doi:10.32598/rj.20.2.190 · Cited by 6 · see citing works
Cognitive dysfunction and neuropsychiatric aspects of Parkinson's disease
Austgen, G., & Marsh, L. (2022) · Progress in brain research · doi:10.1016/bs.pbr.2022.01.009 · Cited by 6 · see citing works
Bipolar Disorder as a Long‐Term Risk Factor for Parkinson's Disease: A Nationwide Case–Control Study
Jaakkola, E., Koponen, M., Kaasinen, V., Hietala, J. A., Hartikainen, S. A., & Tolppanen, A. (2025) · Movement Disorders · doi:10.1002/mds.70135 · Cited by 5 · see citing works
Hearing loss is not associated with risk of Parkinson's disease: A Mendelian randomization study
Ning, P., Mu, X. L., Guo, X., & Li, R. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32533 · Cited by 5 · see citing works
Zhu, T., Mu, D., Hu, Y., Cao, Y., Yuan, M., Xu, J., Ye, H.-Q., & Zhang, W. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03213-2 · Cited by 6 · see citing works
Jung, Y. J., Kim, R., Yoo, D., Han, K., & Lee, J. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01691-9 · Cited by 5 · see citing works
Wang, W., Wang, H., Hu, X., Yu, Q., Chen, F., Qiu, X., & Wang, X. (2025) · JMIR Public Health and Surveillance · doi:10.2196/62730 · Cited by 4 · see citing works
Gorbunova, A. P., Rukavishnikov, G. V., Kasyanov, E. D., & Mazo, G. E. (2023) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2023-5-72-78 · Cited by 4 · see citing works
Xiang, L., Xu, R., Zhou, X., Ren, X., Li, Z., & Wu, I. X. Y. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.03.065 · Cited by 4 · see citing works
Wang, M.-Q., Lu, S., Hao, L., Chen, N., & Xia, Y. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s529339 · Cited by 3 · see citing works
Depression is associated with the nonmotor symptoms of Parkinson's disease: A comparative analysis
Mayeli, M., Shafie, M., Shiravi, M., Parvar, T. A., Mirsepassi, Z., Rahiminejad, F., Sattarpour, R., & Aghamollaii, V. (2024) · Health Science Reports · doi:10.1002/hsr2.2106 · Cited by 3 · see citing works
Liu, D., & Wei, D. (2024) · Medicine · doi:10.1097/md.0000000000039834 · Cited by 3 · see citing works
Davydow, D. S., Okun, M. S., & Pontone, G. M. (2025) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887251319558 · Cited by 3 · see citing works
Morbidity and Associated Factors of Depressive Disorder in Patients With Parkinson's Disease
Lee, Y., Chiou, Y., Chang, Y., Hung, C., Chen, Y., Lin, T., & Wang, L. (2022) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001537 · Cited by 3 · see citing works
Hu, J., Wu, J., Jiang, Q., Wang, Y., Yuan, Y., Cheng, X., Li, K., Shen, Y., Zhang, J., Wang, F., et al. (2024) · Sleep Medicine · doi:10.1016/j.sleep.2024.07.010 · Cited by 3 · see citing works
Sex Differences for Social Determinants Associated with Lewy Body Dementia Onset and Diagnosis
Bayram, E., Wyman‐Chick, K. A., Costello, R., Ghodsi, H., Rivera, C. S., Solomon, L., Kane, J. P. M., & Litvan, I. (2025) · Neurodegenerative Diseases · doi:10.1159/000544772 · Cited by 3 · see citing works
Depression and the risk of Parkinson’s disease: A Mendelian randomization study
Du, Y., Tang, D., Yang, G., & Xu, D. (2025) · Medicine · doi:10.1097/md.0000000000041658 · Cited by 3 · see citing works
Sinaeefar, M. J., Saadat, P., Hamidia, A., & Hosseini, S. R. (2021) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2021.106549 · Cited by 3 · see citing works
Do we need drugs for psychiatric symptoms specifically for Parkinson's disease?
Mills, K. A., & Pontone, G. M. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x251370970 · Cited by 2 · see citing works
Treatment Approaches To Anxiety and Depression in Parkinson’s Disease
Maruca-Sullivan, P. E., Doumlele, K., Keller, S., & Wilkins, K. M. (2025) · Current Geriatrics Reports · doi:10.1007/s13670-025-00436-z · Cited by 2 · see citing works
Xu, B., Liu, X., Barret, O., Tamagnan, G. D., Qiao, H., Lu, J., Zhang, C., Chan, P., & Liu, S. (2025) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70705 · Cited by 2 · see citing works
Clinical characteristics and risk factors of depression in prodromal Parkinson’s disease
Xu, J., Wang, Y., Li, Y., Wang, H., & Liu, W. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1708805 · Cited by 2 · see citing works
Trajectories of late-life depression: insights from molecular imaging
Holmes, S. E., & Smith, G. S. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02340-2 · Cited by 2 · see citing works
Krämer, R. M., Moissl, A. P., Stefan Lorkowski, A., Krämer, B. K., Lehtimäki, T. J., Mishra, B. H., Mishra, P. P., Leipe, J., März, W., Kleber, M. E., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1125151 · Cited by 2 · see citing works
Wei, W.-X., Meng, L., Mao, Z. F., Mo, Z.-H., Yang, L., Qin, Y., & Huang, J. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1590931 · Cited by 2 · see citing works
Neurologic and psychiatric features of impending neurodegeneration in iRBD
Barone, D. A., Sarva, H., Hellmers, N., Wang, F., Xu, Z., Krieger, A. C., & Henchcliffe, C. (2023) · Clinical Parkinsonism & Related Disorders · doi:10.1016/j.prdoa.2023.100216 · Cited by 2 · see citing works
Do enteric glial cells play a role in the pathophysiology of major depression?
Rajkumar, R. P. (2024) · Exploration of neuroscience · doi:10.37349/en.2024.00042 · Cited by 2 · see citing works
Li, R., Ling, Y., Pan, A., Cao, R., Lyu, J., & Bi, W. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1440199 · Cited by 1 · see citing works
Sayfitdinkhuzhaev, Z. F., Жукова, Н. Г., Nasyrova, R. F., Gaponova, O. V., Zhukova, I. A., Masenko, A. Y., & Baydanova, A. N. (2026) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20261260117 · Cited by 1 · see citing works
Liu, D., Qi, C., Huang, J., Xie, H., Zhuang, Y., Zhang, Q., Zhao, X., Hu, T., Qin, G., Lu, Y., et al. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70845 · Cited by 1 · see citing works
Gender Differences and Comorbidities in Major Depression
Jaber, M. H., Kahwaji, H., Eid, D., Atat, M. E., & Fakhoury, M. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-981-95-6872-7_13 · Cited by 1 · see citing works
Depression in neurodegenerative disease: neurobiological mechanisms and emerging treatments
Costello, H., Reeves, S., Glue, P., Young, A. H., & Howard, R. J. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03728-8 · Cited by 1 · see citing works
Use of antiviral drugs and incidence of Parkinson’s disease in Taiwan
Zhang, H., Xie, J., Peng, H.-C., Lin, Y.-S., & Song, J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0302383 · Cited by 1 · see citing works
Affective disorders in Parkinson's disease
nstitute of Psychiatry "Socola", I., Alexinschi, O., Sirițeanu, E.-A., & nstitute of Psychiatry "Socola", I. (2024) · Bulletin of Integrative Psychiatry · doi:10.36219/bpi.2024.2.13 · Cited by 1 · see citing works
Hassan, M. S., Mohamed, N. A., Yavuz, Y., Mohamed, Y. A., & Gökgül, A. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s493161 · Cited by 1 · see citing works
Troubles psychiques et comportementaux
Fénelon, G., Houéto, J., & Robert, G. (2020) · Elsevier eBooks · doi:10.1016/b978-2-294-76802-6.00009-8 · Cited by 1 · see citing works
Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: An Open-Label Pilot TrialPreprint
Bradley, E., Sakai, K., Fernandes‐Osterhold, G., Szigeti, B., Ludwig, C., Ostrem, J. L., Tanner, C. M., Bock, M., Llerena, K., Finley, P. R., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4871260 · Cited by 1 · see citing works
Kazmi, H. (2019) · UCL Discovery (University College London)
Kumagai, R., Kitajima, T., Hirose, M., & Iwata, N. (2020) · PubMed Central · doi:10.20407/fmj.2019-011
- Authors
- Wang, S., Mao, S., Xiang, D., & Fang, C.
- Affiliations
- Renmin Hospital of Wuhan University (CN)
- Corresponding author
- Mao, Shanping
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 86
- Pages
- 186-192
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2806019824
- Cited by
- 128
- References
- 45
- Citations by year
- 2026: 16 · 2025: 26 · 2024: 20 · 2023: 17 · 2022: 17 · 2021: 18 · 2020: 9 · 2019: 5
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Progress in Neuro-Psychopharmacology and Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Neurology › Neurological disorders and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- depression, Parkinson's disease, risk factors, neurodegeneration, disease mechanisms, cohort studies, case-control study
- MeSH terms
- Depression, Depressive Disorder, Humans, Parkinson Disease, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review